These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23943340)

  • 1. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
    Piyaskulkaew C; Singh T; Szpunar S; Saravolatz L; Rosman H
    J Thromb Thrombolysis; 2014 May; 37(4):400-3. PubMed ID: 23943340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
    Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
    Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
    Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
    Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures.
    Palm F; Kleemann T; Dos Santos M; Urbanek C; Buggle F; Safer A; Hennerici MG; Becher H; Zahn R; Grau AJ
    Eur J Neurol; 2013 Jan; 20(1):117-23. PubMed ID: 22788384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
    Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
    Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
    Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
    Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we predict stroke in atrial fibrillation?
    Lip GY
    Clin Cardiol; 2012 Jan; 35 Suppl 1(Suppl 1):21-7. PubMed ID: 22246948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation.
    Hong HJ; Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
    Eur J Neurol; 2012 Feb; 19(2):284-90. PubMed ID: 21914056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation].
    Sun Y; Hu D; ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):846-50. PubMed ID: 25549561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
    Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
    Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
    Olesen JB; Lip GY; Hansen ML; Hansen PR; Tolstrup JS; Lindhardsen J; Selmer C; Ahlehoff O; Olsen AM; Gislason GH; Torp-Pedersen C
    BMJ; 2011 Jan; 342():d124. PubMed ID: 21282258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.
    Larsen TB; Lip GY; Skjøth F; Due KM; Overvad K; Hvilsted Rasmussen L
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):335-42. PubMed ID: 22534406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
    Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
    Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between CHA(2)DS(2)-VASc scores and ischemic stroke/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Tachibana H; Satoh Y; Ozawa M; Kunugita F; Ueda H; Nakamura M
    J Cardiol; 2012 May; 59(3):321-8. PubMed ID: 22386575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.
    Willens HJ; Gómez-Marín O; Nelson K; DeNicco A; Moscucci M
    J Am Soc Echocardiogr; 2013 Feb; 26(2):175-84. PubMed ID: 23253435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
    Lip GY; Frison L; Halperin JL; Lane DA
    Stroke; 2010 Dec; 41(12):2731-8. PubMed ID: 20966417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.
    Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.